France, Michael T.
Ma, Bing
Gajer, Pawel
Brown, Sarah
Humphrys, Michael S.
Holm, Johanna B.
Waetjen, L. Elaine
Brotman, Rebecca M.
Ravel, Jacques http://orcid.org/0000-0002-0851-2233
Funding for this research was provided by:
National Institute on Aging (U01AG012531, U01AG012539, U01AG012546, U01AG012505, U01AG012535, U01AG012553, U01AG012554, U01AG012495)
National Institute of Allergy and Infectious Diseases (U19AI084044, UH2AI083264, R01AI119012)
National Institute of Nursing Research (R01NR015495, U01NR004061)
Article History
Received: 16 September 2020
Accepted: 6 October 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: The internal data used to build and test VALENCIA were derived from archived and de-identified cervicovaginal lavages and swabs. The samples were originally collected after obtaining informed consent by all participants, who also provided consent for storage of the samples and used in future research studies related to women’s health. The original study was approved by the University of Maryland School of Medicine Institutional Review Board.
: Not applicable
: JR is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. All other authors declare that they have no competing interests.